Search

Displaying results 5301 - 5310 of 10000 in total
  1. Drug

    Pucotenlimab

    go.drugbank.com/drugs/DB17552
    ApprovedInvestigational

    It received its first global approval in China in July 2022 for the treatment of solid tumours.[A257296] It is being investigated in other cancers.

  2. Drug

    Allosamidin

    go.drugbank.com/drugs/DB04628
    Experimental

    Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from Candida albicans, and can be utilized as potent antifungal agent.

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Isoluminol

    go.drugbank.com/drugs/DB02041
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Acrylic Acid

    go.drugbank.com/drugs/DB02579
    Investigational

    A α,β-unsaturated monocarboxylic acid that is ethene substituted by a carboxy group.

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Bufogenin

    go.drugbank.com/drugs/DB19835
    Experimental

    Bufogenin is a small molecule drug. Bufogenin has a monoisotopic molecular weight of 384.23 Da.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Nirogacestat

    go.drugbank.com/drugs/DB12005
    ApprovedInvestigational

    3 DeFi trial, where a confirmed objective response rate was observed to be 41% compared to 8% with the placebo. … Desmoid tumors are typically characterized by aberrant activation in Notch signaling.

  7. Drug

    APD668

    go.drugbank.com/drugs/DB05166
    Experimental

    APD668 is a novel, highly potent and orally active glucose-dependent insulinotropic receptor (GDIR) agonist intended to more efficiently stimulate insulin release by beta cells in response to elevated

  8. Drug

    1D09C3

    go.drugbank.com/drugs/DB05121
    Experimental

    1D09C3, a monoclonal antibody against lymphoid cancers, is an anti-MHC (major histocompatibility complex) class II monoclonal antibody. … The antibody was isolated in collaboration with MorphoSys from its HuCAL(R) library of human antibodies. 1D09C3 binds to certain cell surface receptors, selectively killing activated, proliferating MHC

  9. Drug

    Rilapladib

    go.drugbank.com/drugs/DB05119
    Investigational

    Lp-PLA2 is an enzyme associated with the formation of atherosclerotic plaques.

  10. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational